Facts and fiction in the pharmacologic prevention of post-ERCP pancreatitis: a never-ending story.
Testoni
Pier Alberto
PA
D001660:Biliary Tract Diseases / Q000601:surgery; D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005765:Gastrointestinal Agents / Q000008:administration & dosage*; D006801:Humans; D015994:Incidence; D041781:Jaundice, Obstructive / Q000601:surgery; D015282:Octreotide / Q000008:administration & dosage*; D010190:Pancreatic Neoplasms / Q000601:surgery; D019283:Pancreatitis, Acute Necrotizing / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control* / Q000601:surgery
D005765:Gastrointestinal Agents; D015282:Octreotide